Ancient herb meets modern science: could ashwagandha ease PCOS symptoms?

NCT ID NCT07750899

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This trial tests whether a standardized ashwagandha (Withania somnifera) extract, combined with vitamin D and folate, can improve depression, stress, sleep, and metabolic health in women with polycystic ovary syndrome (PCOS). Participants will take either the ashwagandha blend or a comparator supplement daily for a period. Researchers will measure changes in mood questionnaires, stress levels, blood pressure, body composition, and blood markers to see if the herb offers added benefits.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Withania somnifera (ashwagandha) extract combined with vitamin D and folate
What this could lead to
If it works, this could offer a safe, easy-to-use supplement to complement standard PCOS care, potentially improving mood, stress, and metabolic health.
What could go wrong
This is a small early-stage trial, so results may not apply broadly. The supplement may not outperform the active comparator, and individual responses can vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION SYMPTOMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Medical University of Lodz

    Lodz, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.